The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
5-FU + Naliri, gemcitabine plus nab-paclitaxel or both regimens given sequentially for first line treatment of metastatic pancreatic ductal adenocarcinoma: A randomized phase II comparative study (FUNGEMAX-PRODIGE 61).
 
Julien Taieb
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; BMS; Boehringer Ingelheim; Brenus Pharma; Merck KGaA; MSD; natera; Novartis; Pierre Fabre; PROSKOPE; sanofi; SERVIER; takeda
Speakers' Bureau - Amgen; Merck; MSD; Pierre Fabre; SERVIER
 
Simon Pernot
No Relationships to Disclose
 
Frédéric Thuillier
No Relationships to Disclose
 
Alexis Delattre
No Relationships to Disclose
 
Caroline Petorin
No Relationships to Disclose
 
Vincent Bourgeois
No Relationships to Disclose
 
David Tougeron
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; Merck Serono; MSD; Pierre Fabre; Roche; Sanofi; Servier/Pfizer; Takeda
Consulting or Advisory Role - AstraZeneca; BMS; MSD; Novartis; Pierre Fabre; Sanofi; SERVIER; Takeda
Research Funding - BTG (Inst); Gilead Sciences (Inst); MSD (Inst); Pierre Fabre (Inst); Roche (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck Serono; MSD Oncology; Pierre Fabre; Roche; SERVIER
 
Franck Audemar
Expert Testimony - Fresenius Kabi; Merck Serono; Pierre Fabre; Servier/Pfizer
 
Carole Vitellius
No Relationships to Disclose
 
Mosser Laurent
Stock and Other Ownership Interests - CROSSJECT; nanobiotix
 
Jérôme Desrame
Travel, Accommodations, Expenses - Pfizer
 
Frédéric Di Fiore
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; BMS GmbH & Co. KG; Incyte; Ipsen; Merck; MSD; Pierre Fabre; Roche/Genentech; SERVIER; Takeda
Travel, Accommodations, Expenses - Amgen; Ipsen; Lilly; Merck; Novartis; Roche; Sanofi
 
Yves Rinaldi
Honoraria - Amgen Astellas BioPharma; VIATRIS
 
Anna Pellat
Honoraria - MSD Oncology
Consulting or Advisory Role - AstraZeneca; Merck; Servier
Travel, Accommodations, Expenses - Ipsen; Merck; SERVIER
(OPTIONAL) Uncompensated Relationships - ESMO; FFCD; GTE
 
Marion Bolliet
No Relationships to Disclose
 
Fabienne Watelle
No Relationships to Disclose
 
Herve Perrier
No Relationships to Disclose
 
Olivier Dubreuil
Consulting or Advisory Role - Bristol-Myers Squibb/Medarex; Merck Serono; MSD Oncology; Sanofi; SERVIER
Travel, Accommodations, Expenses - Amgen; Amgen; Bristol-Myers Squibb/Medarex; Esteve; Ipsen; Merck Serono; MSD Oncology; Novartis; Sanofi; SERVIER
 
Come Lepage
Honoraria - Amgen; Deciphera; Pierre Fabre; SERVIER; Takeda
Consulting or Advisory Role - Advanced Accelerator Applications
Travel, Accommodations, Expenses - Astellas Pharma; Merck Serono; Pierre Fabre
 
Jean-Baptiste Bachet
Honoraria - Amgen; AstraZeneca; Bayer; Merck Serono; MSD Oncology; Pierre Fabre; SERVIER; Takeda; Takeda; Viatris
Consulting or Advisory Role - Abbvie; Acobiom; Amgen; Bayer; BMS; GlaxoSmithKline; Incyte; Merck Serono; MSD; Servier; Takeda
Travel, Accommodations, Expenses - Amgen; Merck Serono; Roche; Sanofi; Servier